Previous studies have reported that PYCR1, a proline biosynthetic enzyme, was up-regulated in prostate cancer (PCa) compared with normal tissues and it could also promote PCa cell proliferation and colony formation (Nilsson et al., 2014; Zeng et al., 2017). Here, PYCR1 is linked to prostate carcinoma.